Kolexia
Alouani Emily Oncologie médicale
Alouani Emily
Oncologie médicale
Hôpital Rangueil
Toulouse, France
45 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Adénocarcinome Instabilité des microsatellites Tumeurs du sein Tumeurs du côlon Tumeurs de l'estomac Carcinome canalaire du sein Hépatite Tumeurs du péritoine

Collaborateurs

Voir plus
Guimbaud Rosine
Guimbaud Rosine
Hôpital Rangueil, Toulouse, France
Jaffrelot Marion
Jaffrelot Marion
Oncopole Toulouse, Toulouse, France
Hollebecque Antoine
Hollebecque Antoine
Gustave-Roussy, Villejuif, France
Tougeron David
Tougeron David
Hôpital La Miletrie, Poitiers, France

Industries

Voir plus
Servier
6 collaboration(s)
Dernière en 2023
Amgen
5 collaboration(s)
Dernière en 2022
MSD
4 collaboration(s)
Dernière en 2023
Merck-Serono
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Perioperative Chemo and Pembrolizumab in Gastric Cancer: A Phase II Study of Chemotherapy and Immune Checkpoint Blockade With Pembrolizumab in the Perioperative and Maintenance Treatment of Locoregional Gastric or GE Junction Adenocarcinoma.
Essai Clinique (Merck & Co.)   18 janvier 2024
Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of pancreatic ductal adenocarcinoma.
bioRxiv : the preprint server for biology   25 décembre 2023
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
British journal of cancer   15 décembre 2023
Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting.
European journal of cancer (Oxford, England : 1990)   10 novembre 2023
Chemotherapy and Immune Checkpoint Blockade for Gastric and Gastroesophageal Junction Adenocarcinoma.
JAMA oncology   19 octobre 2023
Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology.
European journal of cancer (Oxford, England : 1990)   26 août 2023
Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective multicenter study.
International journal of cancer   05 juillet 2023
Risks and benefits of phase 1 clinical trials for patients with relapsed or refractory lymphoma, from 2008 to 2023
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
Efficacy of immunotherapy in mismatch repair-deficient advanced colorectal cancer in routine clinical practice. An AGEO study.
ESMO open   25 mai 2023
Profile and outcome of cancer patients enrolled in contemporary phase I trials.
European journal of cancer (Oxford, England : 1990)   20 avril 2023